Clinical trial
A Phase I Study of LX-039 Tablets
NCT04097756
Study timeline
Study start (actual)2020-01-07Date precision: day
Registry last updated2023-05-01
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Advanced Breast Cancerunresolved
Interventions
LX-039 tabletsDRUG
Sponsors & collaborators
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04097756 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.